SanBio is a leading Japanese biotechnology company specializing in the development of regenerative medicine. Through innovative cell therapies, SanBio researches new treatment methods for neurological disorders to sustainably improve the quality of life for patients around the world.
Date confirmed from the Tokyo Stock Exchange (JPX) announcement schedule.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
SanBio is scheduled to report its next quarterly earnings on 09/14/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
SanBio last reported quarterly earnings on 6/15/2026 (Q1 2026). Earnings per share (EPS) came in at -10.71 JPY.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.